Asthma Clinical Trials in San Antonio

Showing 101-120 of 254 trials

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

NCT04305405

This study will evaluate the PK, PD and long-term safety of Benralizumab administered subcutaneously in 30 children aged 6 to 11 years with severe eosinophilic asthma. Up to an additional 3 Japanese patients aged 12 to 14 years will be enrolled to meet local regulatory requirements.

Severe Uncontrolled Asthma

AstraZeneca30 participantsStarted Nov 2019

Los Angeles, California, United States • Orlando, Florida, United States • Lincoln, Nebraska, United States +12 more locations

TERMINATEDPhase 2< 1 mile

A Study to Test if TEV-48574 is Effective in Relieving Asthma

NCT04545385

The primary objective of the study is to evaluate the effect of TEV-48574 compared with placebo on loss of asthma control (LoAC) in adult participants with T2-low and non-T2 severe asthma uncontrolled on inhaled corticosteroids plus long-acting beta-agonists (ICS+LABA). The secondary efficacy objective is to evaluate the effect of TEV-48574 compared with placebo on a range of clinical measures of asthma control. The duration of participant participation in the study is planned to be up to approximately 30 weeks.

Asthma

Teva Branded Pharmaceutical Products R&D, Inc.65 participantsStarted Oct 2020

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +94 more locations

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Asthma Trials in Other Cities

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Plasma Adsorption in Patients With Confirmed COVID-19

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

Other Conditions in San Antonio